Does lens status affect the course of early intraocular pressure and anterior chamber changes after intravitreal injection?

Acta Ophthalmologica

Volumn 89, Issue 2, 2011, Pages 138-142

  Kerimoglu, Hurkan ^a   Ozturk, Banu T ^a   Bozkurt, Banu ^a   Okka, Mehmet ^a   Okudan, Suleyman ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Anterior chamber depth; Intraocular pressure; Intravitreal injection; Lens status

Indexed keywords

KENOLOG; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ANTERIOR EYE CHAMBER; ANTERIOR EYE CHAMBER DEPTH; ANTERIOR EYE CHAMBER VOLUME; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETIC MACULAR EDEMA; ENDOPHTHALMITIS; HUMAN; INTRAOCULAR HEMORRHAGE; INTRAOCULAR PRESSURE; LENS; OBSERVATIONAL STUDY; PHAKIC INTRAOCULAR LENS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOPHAKIA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; VISUAL SYSTEM PARAMETERS; VITREOUS HAEMORRHAGE;

ANTERIOR CHAMBER; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; LENS, CRYSTALLINE; MIDDLE AGED; PROSPECTIVE STUDIES; PSEUDOPHAKIA; TRIAMCINOLONE ACETONIDE;

EID: 79952214266     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01656.x     Document Type: Article

References (29)

1. Baath J, Ells AL, Crichton A, Kherani A & Williams RG (2007): Safety profile of intravitreal triamcinolone acetonide. J Ocul Pharmacol Ther 23: 304-310. (Pubitemid 46986612)
2. Benz MS, Albini TA, Holz ER, Lakhanpal RR, Westfall AC, Iyer MN & Carvounis PE (2006): Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology 113: 1174-1178. (Pubitemid 43947221)
3. Cekic O, Chang S, Tseng JJ, Akar Y, Barile GR & Schiff WM (2005): Cataract progression after intravitreal triamcinolone injection. Am J Ophthalmol 139: 993-998.
4. Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB & Billson FA (1998): Exudative macular degeneration and intravitreal triamcinolone: 18-month follow-up. Aust N Z J Ophthalmol 26: 277-281. (Pubitemid 28529891)
5. Danis RP, Ciulla TA, Pratt LM & Anliker W (2000): Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20: 244-250. (Pubitemid 30436775)
6. Gillies MC, Simpson JM, Billson FA et al. (2004): Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol 122: 336-340. (Pubitemid 38314193)
7. Hayashi K, Hayashi H, Nakao F & Hayashi F (2000): Changes in anterior chamber angle width and depth after intraocular lens implantation in eyes with glaucoma. Ophthalmology 107: 698-703. (Pubitemid 30191336)
8. Hayreh SS, Kolder HE & Weingeist TA (1980): Central retinal artery occlusion and retinal tolerance time. Ophthalmology 87: 75-78. (Pubitemid 10196118)
9. Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi BA, Gangnon RE & Puliafito CA (2004): Intravitreal triamcinolone for the treatment of macular oedema associated with central retinal vein occlusion. Arch Ophthalmol 122: 1131-1136. (Pubitemid 39031127)
10. Jonas JB, Kreissig I & Degenring R (2003): Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 87: 24-27. (Pubitemid 36071773)
11. Jonas JB, Akkoyun I, Kamppeter B, Kreissig I & Degenring RF (2005a): Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye 19: 65-71. (Pubitemid 40192642)
12. Jonas JB, Akkoyun I, Kreissig I & Degenring RF (2005b): Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomized study. Br J Ophthalmol 89: 321-326. (Pubitemid 40327617)
13. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E & Baumal C (2002): Intravitreal triamcinolone for refractory diabetic macular oedema. Ophthalmology 109: 920-927. (Pubitemid 34465226)
14. Meyer MA, Savitt ML & Kopitas E (1997): The effect of phacoemulsification on aqueous outflow facility. Ophthalmology 104: 1221-1227. (Pubitemid 28048717)
15. Nemeth G, Vajas A, Kolozsvari B, Berta A & Modis L Jr (2006): Anterior chamber depth measurements in phakic and pseudophakic eyes: Pentacam versus ultrasound device. J Cataract Refract Surg 32: 1331-1335.
16. Poley BJ, Lindstrom RL & Samuelson TW (2008): Longterm effects of phacoemulsification with intraocular lens implantation in normotensive and ocular hypertensive eyes. J Cataract Refract Surg 34: 735-742. (Pubitemid 351615516)
17. Rabsilber TM, Khoramnia R & Auffarth GU (2006): Anterior chamber measurements using Pentacam rotating Scheimpflug camera. J Cataract Refract Surg 32: 456-459.
18. Radius RL & Anderson DR (1981): Reversibility of optic nerve damage in primate eyes subjected to intraocular pressure above systolic blood pressure. Br J Ophthalmol 65: 661-672. (Pubitemid 12228451)
19. Rodrigues EB, Meyer CH, Grumann A Jr, Shiroma H, Aguni JS & Farah ME (2007): Tunnelled scleral incision to prevent vitreal reflux after intravitreal injection. Am J Ophthalmol 143: 1035-1037. (Pubitemid 46764639)
20. Schmidt JC, Meyer CH & Mennel S (2007): Pars plana vitrectomy with anterior chamber infusion via a paracentesis in pseudophakic eyes. Ophthalmologe 104: 222-225.
21. Shingleton BJ, Gamell LS, O'Donoghue MW, Baylus SL & King R (1999): Longterm changes in intraocular pressure after clear corneal phacoemulsification: normal patients versus glaucoma suspect and glaucoma patients. J Cataract Refract Surg 25: 885-890. (Pubitemid 29309783)
22. Shingleton BJ, Pasternack JJ, Hung JW & O'Donoghue MW (2006): Three- and fiveyear changes in intraocular pressures after clear corneal phacoemulsification in openangle glaucoma patients, glaucoma suspects, and normal patients. J Glaucoma 15: 494-498. (Pubitemid 44760322)
23. Singh IP, Ahmad SI, Yeh D, Challa P, Herndon LW, Allingham RR & Lee PP (2004): Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Am J Ophthalmol 138: 286-287. (Pubitemid 39037435)
24. Smithen LM, Ober MD, Maranan L & Spaide RF (2004): Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 138: 740-743. (Pubitemid 39452920)
25. Spaide RF, Sorenson J & Maranan L (2005): Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112: 301-304. (Pubitemid 40202568)
26. Strenk SA & Strenk LM (2007): In Vivo MRI Visualizing the Haptics. Eye World. American Society of Cataract & Refractive Surgery (ASCRS). http://www.eyeworld.org/article.php?sid=4004. [Accessed 30 March 2009].
27. Tong JT & Miller KM (1999): Longterm intraocular pressure changes after phacoemulsification. J Cataract Refract Surg 25: 1560.
28. Wang L & Song H (2009): Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion. Acta Ophthalmol 87: 285-289.
29. Westfall AC, Osborn A, Kuhl D, Benz MS, Mieler WF & Holz ER (2005): Acute endophthalmitis incidence: intravitreal triamcinolone. Arch Ophthalmol 123: 1075-1077. (Pubitemid 41159300)